Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration
- PMID: 35691217
- PMCID: PMC9130304
- DOI: 10.1016/j.jiph.2022.05.009
Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration
Abstract
Background: Since the COVID-19 pandemic has started, Serbia has faced problems in implementing proper public health measures in the population, including non-pharmaceutical interventions, as well as protecting health care workers (HCWs) from disease, like all other countries. This study aimed to estimate COVID-19 seroprevalence and evaluate the risk perception of COVID-19 among HCWs in three different hospitals in Belgrade, Serbia: non-COVID hospital, Emergency Center (EC), and dedicated COVID hospital.
Methods: A cross-sectional study was conducted in three hospitals during the second wave of the outbreak in Serbia, from June to early October. All staff in these hospitals were invited to voluntarily participate in blood sampling for IgG antibodies against SARS-CoV-2 and questionnaire testing. The questionnaire included socio-demographic characteristics, known exposure to COVID-19 positive persons, previous signs and symptoms related to COVID-19 infection since the outbreak had started in our country, and SARS-CoV-2 PCR testing.
Results: The overall prevalence of SARS-CoV-2 antibody among 1580 HCWs was 18.3 % [95 % CI 16.4-20.3 %]. Significantly higher prevalence of HCWs with positive results for the serum IgG antibody test was observed in COVID hospital (28.6 %, 95 %CI: 24.0-33.6 %) vs. prevalence in the EC (12.6 %, 95 %CI: 10.1-15.4 %), and in the non-COVID hospital (18.3 %, 95 %CI: 15.2-26.7 %). The prevalence adjusted for declared test sensitivity and specificity would be 16.8 %; that is 27.4 % in COVID-19 hospital, 10.9 % in EC, and 16.8 % in non-COVID hospital. In multivariate logistic regression analysis, the independent predictors for seropositivity were working in COVID-hospital, the profession of physician, and the presence of the following symptoms: fever, shortness of breath, and anosmia/ageusia.
Conclusions: We found an overall seropositivity rate of 18.3 % and 16.0 % of the adjusted rate that is higher than seroprevalence obtained in similar studies conducted before vaccinations started. The possibility that patients in non-COVID dedicated hospitals might also be infectious, although PCR tested, imposes the need for the use of personal protective equipment also in non-COVID medical institutions.
Keywords: COVID-19; Healthcare workers; Hospital; Serology; Seroprevalence.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1. Eur J Cancer. 2022. PMID: 35189537 Free PMC article.
-
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.Front Public Health. 2022 Mar 24;10:832003. doi: 10.3389/fpubh.2022.832003. eCollection 2022. Front Public Health. 2022. PMID: 35400056 Free PMC article.
-
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5. Infect Dis (Lond). 2021. PMID: 34350813
-
Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence.Health Policy Plan. 2022 Apr 13;37(4):505-513. doi: 10.1093/heapol/czab133. Health Policy Plan. 2022. PMID: 34726740 Free PMC article.
-
The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.PLoS One. 2021 Nov 2;16(11):e0250541. doi: 10.1371/journal.pone.0250541. eCollection 2021. PLoS One. 2021. PMID: 34727115 Free PMC article.
Cited by
-
Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia.Vaccines (Basel). 2022 Dec 16;10(12):2168. doi: 10.3390/vaccines10122168. Vaccines (Basel). 2022. PMID: 36560578 Free PMC article.
-
COVID-19 Seroprevalence in Romania: Insights from a Nationwide Antibody Study.Epidemiologia (Basel). 2025 Jun 4;6(2):26. doi: 10.3390/epidemiologia6020026. Epidemiologia (Basel). 2025. PMID: 40558600 Free PMC article.
References
-
- Ministry of Health or Republic of Serbia. First case of COVID-19, 〈https://www.zdravlje.gov.rs/vest/346180/registrovan-prvi-oboleli-od-cov...; 2021[accessed 8 March 2021].
-
- Institute of Public Health of Serbia. Belgrade, Republic Expert Committee for healthcare-associated infections. Guideline of prevention and control of SARS-CoV-2 transmission in the health care facilities [in Serbian], 〈https://www.batut.org.rs/download/aktuelno/MereprevencijeSARS-CoV-2zdra...; 2021[accessed 15 September 2021].
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous